by Medical University of Vienna Credit: Unsplash/CC0 Public Domain In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the current “gold standard” treatment for this autoimmune disease. This opens up new treatment options for affected patients. The results of the international...
Tag: <span>rheumatoid arthritis</span>
Sleep problems not a major issue in rheumatoid arthritis
Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis, according to a study recently published in RMD Open. Lauren Lyne, from the Karolinska Institutet in Stockholm, and colleagues investigated sleep quality and duration in 3,265 patients with newly diagnosed rheumatoid arthritis (1998 to 2018) and during one to 12 years after diagnosis. The researchers found...
Passive smoking linked to increased risk of rheumatoid arthritis
APRIL 15, 2022 Passive smoking during childhood and/or adulthood is associated with increased risk of rheumatoid arthritis (RA), according to a study recently published in RMD Open. Yann Nguyen, M.D., M.P.H., from the Université Paris-Saclay in Villejuif, France, and colleagues examined the association between exposure to passive smoking and the risk of incident RA in a...
Study: Older adults with rheumatoid arthritis still undermedicated, despite aggressive guidelines
by Noah Fromson, University of Michigan A graphic of a patient visiting a physician for rheumatoid arthritis. Credit: Jacob Dwyer, Michigan Medicine Despite guidelines that call for early and aggressive treatment of rheumatoid arthritis, a new study suggests many older adults are not prescribed disease-modifying medications for their inflammatory autoimmune disease. Researchers at Michigan Medicine...
Factors linked to excess disability identified in rheumatoid arthritis
(HealthDay)—For patients with rheumatoid arthritis (RA), higher pain, fatigue, and depressive symptoms are associated with increased odds of being in the high disability trajectory, despite similar levels of inflammation, according to a study published online March 11 in Rheumatology. James M. Gwinnutt, Ph.D., from the University of Manchester in the United Kingdom, and colleagues used data...
How to manage morning stiffness with rheumatoid arthritis
Many with people with rheumatoid arthritis are familiar with stiff joints in the morning. But what causes this morning stiffness, and how can people get rid of it? Rheumatoid arthritis (RA) is an autoimmune condition that attacks the joints, causing inflammation, pain, and stiffness, including morning stiffness. Morning stiffness is a widespread problem among those with RA....
Frailty may be reversible for some people with rheumatoid arthritis
by University of Glasgow Credit: Unsplash/CC0 Public Domain Rheumatoid arthritis patients living with frailty may find their frailty is reversible following treatment, according to a new study. The research, published in RMD Open and led by the University of Glasgow, looked at frailty—a vulnerability to poor health-outcomes—in people with rheumatoid arthritis (RA). The study used data...
Predicting the progression of rheumatoid arthritis
by Tokyo Medical and Dental University PRS of patients with severe radiographic progression was significantly higher than that of patients with non-severe progression. Credit: Department of Genomic Function and Diversity, TMDUPredicting the future may be beyond our grasp, but what about predicting disease progression? Researchers in Japan have delved into the human genome to investigate...
2 rheumatoid arthritis drugs tied to lower risk of Parkinson’s
(HealthDay)—Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced...
Newer rheumatoid arthritis drug might raise heart, cancer risks
by Amy Norton (HealthDay)—Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food and Drug Administration after earlier safety signals about the drug, called...